Artificial pancreas systems increase time in blood glucose target range by nearly 3 hours per day compared with conventional pump therapy in outpatients with type 1 diabetes, meta-analysis data show.

A pooled analysis of large prospective studies shows that having an increased body mass index raises people’s risk for developing multiple cardiometabolic problems, with this risk apparent even in the overweight category.

Comment on: Retention key for US national diabetes prevention efforts

Data from the first 4 years of implementation of the US National Diabetes Prevention Program show promising results, with the more engaged patients achieving the best outcomes.

Read the linked commentary from Leonard Bertheau.

Patients with type 2 diabetes who experience hypoglycemia during sulfonylurea treatment are at greater risk for cardiovascular events than those who do not experience hypoglycemia, results of a US study suggest.

The 24th European Congress on Obesity is taking place this week in Porto, Portugal, with key presentations including the findings from the World Health Organization’s Health Behaviour in School-aged Children survey.